Stay updated on NIMBLe Study: Clinical Trial_hyperMutated Cancers
Sign up to get notified when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.

Latest updates to the NIMBLe Study: Clinical Trial_hyperMutated Cancers page
- Check6 days agoChange DetectedThe page now shows a 403 Forbidden error (with basic navigation like Home and a revision banner), and the previously listed trial content appears to be removed, indicating the study record is no longer accessible.SummaryDifference19%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision label updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor system update. No substantive study content appears to be affected.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter revision label changed from v3.6.4 to v3.6.5. This reflects a minor page update without changes to the study details or content.SummaryDifference0.1%

- Check55 days agoChange DetectedNo additions or deletions were provided, so there is nothing to describe about the page changes.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the study record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision line was updated from v3.6.2 to v3.6.3. This indicates a minor platform update to the study record page.SummaryDifference0.1%

Stay in the know with updates to NIMBLe Study: Clinical Trial_hyperMutated Cancers
Enter your email address, and we'll notify you when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.